Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
Cancer in Central and South America
MEXICO
This country profile for the Cancer in Central and South America project provides, for each participating cancer registry tables and graphics showing numbers of cases and rates by year, sex and age group for major sites of cancer together with a population pyramid. A country summary is also provided based on aggregated registry data and national mortality data from the WHO mortality database: (http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html) Citation of any of these data should be in the following format: “Sierra MS, Abriata MG, Barrios E, Bravo LE, Cueva P, Fernandez L, Pineros M, Rebelo M, de Vries E, Forman D. Editors on behalf of the Cancer in Central and South America Working Group (2016). Cancer in Central and South America. Lyon: International Agency for Research on Cancer. Available from: http://www-dep.iarc.fr/CSU_resources.htm accessed [date].”
http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.htmlhttp://www-dep.iarc.fr/CSU_resources.htm
Registry Summary Tables and Figures
MEXICO, JALISCO (2006-2011)
Registry Director*: Dr María de las Mercedes Basulto Monroy
Registry Staff*: Jaime Agustín González Álvarez, Luis Daniel Meraz Rosales, Vanesa Lizette Vizcarra Murguía, Pilar Ruiz Gaytan López, Elba Maria Ramos Figueroa, Rubén Sandoval Gloria, María Teresa García Mata.
*Director and staff as notified at time of call for data in 2013. Current contact information for cancer registries in the
region can be found at: http://www.iacr.com.fr/index.php?option=com_comprofiler&task=usersList&listid=5.
CSA - 2
http://www.iacr.com.fr/index.php?option=com_comprofiler&task=usersList&listid=5
MEXICO, JALISCO (2006-2010)Number of Cases in Major Diagnosis Groups
per Calendar Year
YEAR
SITE 2006n (%)2007n (%)
2008n (%)
2009n (%)
2010n (%)
TOTALn (%)
MALESLip, oral cavity, and pharynx (C00-C14) 68 (2.0) 83 (2.3) 57 (1.7) 64 (1.8) 85 (2.5) 357 (2.1)Digestive organs (C15-C26) 410 (12.3) 475 (13.4) 459 (13.3) 436 (12.4) 516 (15.3) 2296 (13.3)Respiratory organs (C30-C39) 227 (6.8) 243 (6.9) 219 (6.4) 267 (7.6) 240 (7.1) 1196 (7.0)Bone, cartilage, and skin (C40-C44) 805 (24.2) 872 (24.6) 895 (26.0) 867 (24.7) 850 (25.1) 4289 (24.9)Breast (C50) 4 (0.1) 7 (0.2) 8 (0.2) 3 (0.1) 8 (0.2) 30 (0.2)Male genitalia (C60-C63) 908 (27.3) 927 (26.2) 920 (26.7) 919 (26.2) 802 (23.7) 4476 (26.0)Urinary organs (C64-C68) 225 (6.8) 222 (6.3) 225 (6.5) 211 (6.0) 232 (6.9) 1115 (6.5)Eye, brain, and thyroid (C69-C75) 141 (4.2) 124 (3.5) 138 (4.0) 134 (3.8) 168 (5.0) 705 (4.1)Hematopoietic (C81-C96) 367 (11.0) 366 (10.3) 317 (9.2) 382 (10.9) 302 (8.9) 1734 (10.1)Other and unspecified 176 (5.3) 220 (6.2) 210 (6.1) 222 (6.3) 179 (5.3) 1007 (5.9)All sites 3331 (100.0) 3539 (100.0) 3448 (100.0) 3505 (100.0) 3382 (100.0) 17205 (100.0)
FEMALESLip, oral cavity, and pharynx (C00-C14) 50 (1.2) 40 (0.9) 47 (1.1) 34 (0.8) 42 (1.0) 213 (1.0)Digestive organs (C15-C26) 427 (10.1) 464 (10.0) 370 (8.5) 441 (10.1) 461 (10.8) 2163 (9.9)Respiratory organs (C30-C39) 119 (2.8) 128 (2.8) 113 (2.6) 124 (2.9) 118 (2.8) 602 (2.8)Bone, cartilage, and skin (C40-C44) 951 (22.5) 949 (20.5) 969 (22.2) 1004 (23.1) 976 (22.8) 4849 (22.2)Breast (C50) 1022 (24.2) 1258 (27.2) 1238 (28.4) 1137 (26.2) 1164 (27.2) 5819 (26.6)Female genitalia (C51-C58) 760 (18.0) 858 (18.6) 748 (17.1) 629 (14.5) 702 (16.4) 3697 (16.9)Urinary organs (C64-C68) 110 (2.6) 125 (2.7) 107 (2.5) 108 (2.5) 95 (2.2) 545 (2.5)Eye, brain, and thyroid (C69-C75) 255 (6.0) 260 (5.6) 290 (6.6) 257 (5.9) 266 (6.2) 1328 (6.1)Hematopoietic (C81-C96) 303 (7.2) 303 (6.6) 277 (6.3) 346 (8.0) 262 (6.1) 1491 (6.8)Other and unspecified 225 (5.3) 236 (5.1) 207 (4.7) 267 (6.1) 196 (4.6) 1131 (5.2)All sites 4222 (100.0) 4621 (100.0) 4366 (100.0) 4347 (100.0) 4282 (100.0) 21838 (100.0)
BOTH SEXESLip, oral cavity, and pharynx (C00-C14) 118 (1.6) 123 (1.5) 104 (1.3) 98 (1.2) 127 (1.7) 570 (1.5)Digestive organs (C15-C26) 837 (11.1) 939 (11.5) 829 (10.6) 877 (11.2) 977 (12.7) 4459 (11.4)Respiratory organs (C30-C39) 346 (4.6) 371 (4.5) 332 (4.2) 391 (5.0) 358 (4.7) 1798 (4.6)Bone, cartilage, and skin (C40-C44) 1756 (23.2) 1821 (22.3) 1864 (23.9) 1871 (23.8) 1826 (23.8) 9138 (23.4)Urinary organs (C64-C68) 335 (4.4) 347 (4.3) 332 (4.2) 319 (4.1) 327 (4.3) 1660 (4.3)Eye, brain, and thyroid (C69-C75) 396 (5.2) 384 (4.7) 428 (5.5) 391 (5.0) 434 (5.7) 2033 (5.2)Hematopoietic (C81-C96) 670 (8.9) 669 (8.2) 594 (7.6) 728 (9.3) 564 (7.4) 3225 (8.3)Other and unspecified 401 (5.3) 456 (5.6) 417 (5.3) 489 (6.2) 375 (4.9) 2138 (5.5)All sites 7553 (100.0) 8160 (100.0) 7814 (100.0) 7852 (100.0) 7664 (100.0) 39043 (100.0)
1
CSA - 3
MEXICO, JALISCO (2006-2010)Age Standardized Rate (World Population) per 100,000
in Major Diagnosis Groups per Calendar Year
YEAR
SITE 2006ASR (%)2007
ASR (%)2008
ASR (%)2009
ASR (%)2010
ASR (%)TOTAL
ASR (%)
MALESLip, oral cavity, and pharynx (C00-C14) 2.6 (2.1) 3.1 (2.4) 2.1 (1.7) 2.2 (1.8) 2.8 (2.5) 2.6 (2.1)Digestive organs (C15-C26) 15.7 (12.5) 17.9 (13.7) 16.8 (13.6) 15.3 (12.6) 17.4 (15.3) 16.6 (13.5)Respiratory organs (C30-C39) 8.9 (7.1) 9.3 (7.2) 8.2 (6.6) 9.6 (8.0) 8.3 (7.3) 8.9 (7.2)Bone, cartilage, and skin (C40-C44) 30.0 (23.9) 32.4 (24.9) 32.0 (25.9) 30.0 (24.8) 28.6 (25.1) 30.6 (24.9)Breast (C50) 0.2 (0.1) 0.3 (0.2) 0.3 (0.2) 0.1 (0.1) 0.3 (0.3) 0.2 (0.2)Male genitalia (C60-C63) 35.9 (28.6) 34.8 (26.7) 34.0 (27.5) 32.2 (26.6) 27.6 (24.2) 32.7 (26.7)Urinary organs (C64-C68) 8.9 (7.1) 8.3 (6.4) 8.3 (6.7) 7.4 (6.1) 8.2 (7.2) 8.2 (6.7)Eye, brain, and thyroid (C69-C75) 4.8 (3.8) 4.3 (3.3) 4.5 (3.7) 4.3 (3.5) 5.4 (4.7) 4.7 (3.8)Hematopoietic (C81-C96) 12.2 (9.7) 12.1 (9.3) 10.4 (8.4) 12.2 (10.1) 9.6 (8.4) 11.3 (9.2)Other and unspecified 6.5 (5.2) 8.0 (6.1) 7.2 (5.8) 7.7 (6.4) 5.8 (5.1) 7.0 (5.7)All sites 125.5 (100.0) 130.4 (100.0) 123.5 (100.0) 121.0 (100.0) 113.7 (100.0) 122.6 (100.0)
FEMALESLip, oral cavity, and pharynx (C00-C14) 1.6 (1.2) 1.2 (0.9) 1.4 (1.1) 1.0 (0.8) 1.2 (1.0) 1.3 (1.0)Digestive organs (C15-C26) 14.5 (10.6) 15.1 (10.5) 11.4 (8.6) 13.2 (10.2) 13.6 (11.1) 13.5 (10.2)Respiratory organs (C30-C39) 4.2 (3.1) 4.3 (3.0) 3.6 (2.7) 3.9 (3.0) 3.4 (2.8) 3.9 (2.9)Bone, cartilage, and skin (C40-C44) 30.4 (22.1) 29.4 (20.4) 29.4 (22.1) 29.3 (22.6) 27.6 (22.4) 29.2 (21.9)Breast (C50) 33.3 (24.2) 39.4 (27.3) 37.8 (28.5) 33.8 (26.1) 33.7 (27.3) 35.6 (26.7)Female genitalia (C51-C58) 24.8 (18.1) 27.0 (18.7) 22.5 (16.9) 18.5 (14.3) 19.9 (16.1) 22.4 (16.8)Urinary organs (C64-C68) 3.8 (2.7) 3.9 (2.7) 3.5 (2.6) 3.4 (2.6) 2.8 (2.3) 3.4 (2.6)Eye, brain, and thyroid (C69-C75) 7.9 (5.7) 7.7 (5.4) 8.6 (6.4) 7.6 (5.9) 7.5 (6.1) 7.9 (5.9)Hematopoietic (C81-C96) 9.7 (7.1) 9.1 (6.3) 8.3 (6.2) 10.4 (8.1) 7.8 (6.3) 9.0 (6.8)Other and unspecified 7.2 (5.3) 7.1 (4.9) 6.4 (4.8) 8.1 (6.3) 5.8 (4.7) 6.9 (5.2)All sites 137.4 (100.0) 144.3 (100.0) 132.8 (100.0) 129.3 (100.0) 123.3 (100.0) 133.1 (100.0)
BOTH SEXESLip, oral cavity, and pharynx (C00-C14) 2.1 (1.6) 2.1 (1.5) 1.7 (1.3) 1.5 (1.2) 2.0 (1.7) 1.9 (1.5)Digestive organs (C15-C26) 15.0 (11.4) 16.4 (12.0) 13.9 (10.9) 14.2 (11.4) 15.3 (13.0) 15.0 (11.7)Respiratory organs (C30-C39) 6.4 (4.9) 6.6 (4.8) 5.7 (4.5) 6.5 (5.2) 5.6 (4.8) 6.2 (4.8)Bone, cartilage, and skin (C40-C44) 30.2 (23.0) 30.7 (22.4) 30.6 (23.9) 29.5 (23.7) 28.0 (23.7) 29.8 (23.4)Urinary organs (C64-C68) 6.1 (4.7) 5.9 (4.3) 5.7 (4.5) 5.2 (4.2) 5.3 (4.5) 5.6 (4.4)Eye, brain, and thyroid (C69-C75) 6.4 (4.9) 6.1 (4.4) 6.6 (5.2) 6.1 (4.9) 6.5 (5.5) 6.3 (5.0)Hematopoietic (C81-C96) 10.9 (8.3) 10.6 (7.7) 9.3 (7.3) 11.3 (9.0) 8.6 (7.3) 10.1 (7.9)Other and unspecified 6.9 (5.2) 7.5 (5.5) 6.7 (5.3) 7.9 (6.4) 5.8 (4.9) 7.0 (5.5)All sites 131.1 (100.0) 137.0 (100.0) 127.8 (100.0) 124.8 (100.0) 118.3 (100.0) 127.5 (100.0)
1
CSA - 4
MEXICO
,JAL
ISCO
(200
6-20
10)
Incid
ence
per1
00,00
0byA
geGr
oup(yea
rs)
Males
SITE
ALL
CASE
SUN
KAG
E0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
CRUD
ERA
TEAS
R(W
)CU
M.RA
TE(0-74)†
MV (%)
DCO
(%)
Rank‡
ICD1
0
Lip,o
ralcavity,a
ndph
arynx(
C00-14
)35
724
..
.0.2
0.50.5
0.41.1
1.42.7
4.98.3
9.113
.112
.118
.52.1
2.60.2
910
00
12C0
0-14
Oesoph
agus
(C15
)14
610
..
..
.0.1
.0.2
0.81.5
1.72.8
4.37.0
5.68.4
0.91.1
0.13
100
018
C15
Stom
ach(
C16)
643
530.1
..
..
0.31.3
2.12.8
4.97.4
11.4
16.0
23.8
31.5
37.6
3.84.6
0.55
100
05
C16
Colon
(C18
)66
247
..
.0.2
0.41.0
1.32.2
2.76.4
8.514
.616
.719
.833
.229
.53.9
4.70.5
810
00
C18
Rectu
m(C19
-20)
365
35.
.0.1
.0.1
0.40.7
1.51.9
2.34.9
6.78.7
13.4
15.9
17.7
2.12.6
0.31
100
0C1
9-20
Color
ectal
(C18
-20)
1027
82.
.0.1
0.20.4
1.42.1
3.74.6
8.713
.321
.325
.433
.249
.147
.26.0
7.40.8
910
00
2C1
8-20
Anus
(C21
)13
1.
..
..
.0.1
.0.1
0.10.4
.0.5
0.30.4
0.30.1
0.10.0
110
00
27C2
1Co
lon,rectum
anda
nus(
C18-21
)10
4083
..
0.10.2
0.41.4
2.23.7
4.78.8
13.8
21.3
25.8
33.5
49.5
47.5
6.17.5
0.90
100
0C1
8-21
Liver
(C22
)34
1.
..
..
..
.0.1
0.40.4
0.70.7
2.11.7
2.00.2
0.30.0
310
00
23C2
2Ga
llblad
der(C2
3-24
)13
917
..
..
.0.1
0.30.2
0.70.9
1.42.0
4.84.6
7.86.9
0.81.0
0.13
100
019
C23-24
Pancreas
(C25
)18
26
..
..
..
0.10.2
0.82.2
2.85.0
5.96.7
10.3
6.71.1
1.40.1
810
00
16C2
5No
se,sinu
ses(
C30-31
)31
00.1
0.1.
0.10.1
.0.4
0.10.4
0.1.
0.70.5
0.9.
2.00.2
0.20.0
210
00
26C3
0-31
Laryn
x(C3
2)30
612
..
..
.0.2
0.10.5
0.61.8
3.54.8
10.3
17.1
15.9
20.8
1.82.3
0.28
100
013
C32
Lung
,trache
aand
bron
chus
(C33
-34)
814
58.
..
0.1.
0.50.4
1.02.3
3.57.8
16.7
21.2
35.7
53.9
55.0
4.86.1
0.77
100
03
C33-34
Melan
omao
fskin
(C43
)30
124
.0.2
0.10.1
0.10.3
1.01.2
2.42.8
3.34.4
7.18.5
8.216
.51.8
2.10.2
210
00
14C4
3Me
sothe
lioma
(C45
)31
4.
..
0.1.
0.1.
0.10.2
0.20.4
0.40.7
1.20.4
1.70.2
0.20.0
210
00
24C4
5Ka
posisarco
ma(C46
)72
13.
..
.0.1
0.50.7
0.51.1
0.30.4
0.70.7
0.90.9
1.20.4
0.40.0
410
00
22C4
6Brea
st(C50
)30
3.
..
..
..
0.10.4
0.20.1
0.20.7
1.21.7
2.00.2
0.20.0
310
00
25C5
0Pe
nis(C60
)14
26
..
..
0.10.1
0.11.0
0.81.5
1.32.0
4.34.3
4.79.8
0.81.0
0.11
100
020
C60
Prostat
e(C6
1)37
7959
5.
..
0.1.
0.30.7
1.92.0
5.615
.743
.810
2.618
8.728
1.328
8.022
.128
.93.8
110
00
1C6
1Testis(C6
2)54
329
0.60.1
0.63.2
7.78.0
6.63.5
1.71.5
1.01.4
0.91.8
2.22.3
3.22.9
0.21
100
010
C62
Kidn
ey(C64
)46
628
1.20.3
0.20.1
0.20.4
0.41.3
2.14.7
5.89.4
12.1
17.4
25.9
14.2
2.73.4
0.43
100
09
C64
Blad
der(C6
7)63
164
..
..
0.10.2
0.40.7
1.43.1
5.06.7
18.3
27.1
32.7
54.1
3.74.6
0.53
100
06
C67
Brain
,CNS
(C70
-72)
416
272.1
1.80.8
0.40.9
1.51.8
2.51.9
2.94.9
6.78.5
5.58.6
4.92.4
2.70.2
710
00
11C7
0-72
Thyro
id(C73
)18
49
..
.0.1
0.40.9
1.31.4
1.61.6
1.73.7
3.93.4
5.64.3
1.11.2
0.13
100
017
C73
Hodg
kindis
ease
(C81
)23
121
0.20.6
1.01.3
1.61.5
1.01.2
0.81.5
1.41.4
1.63.0
3.93.8
1.31.4
0.12
100
015
C81
Non-Ho
dgkin
lymph
oma(
C82-85
,C96
)77
565
1.41.6
1.11.1
1.62.8
2.13.1
4.05.7
7.89.8
12.6
19.8
26.7
29.2
4.55.2
0.55
100
04
C82-85
,C96
Multip
lemy
eloma
(C88
+C90
)119
2.
..
..
0.10.1
.0.6
1.10.8
4.36.9
4.94.7
3.50.7
0.90.1
210
00
21C8
8+C9
0Lymp
hoidleu
kaem
ia(C91
)38
510
5.83.2
3.01.6
1.70.8
1.00.7
0.40.7
1.41.8
2.11.8
2.68.1
2.22.4
0.15
100
0C9
1My
eloidleu
kaem
ia(C92
-94)
221
21.0
0.70.4
0.61.0
0.81.3
1.21.8
1.61.5
2.83.0
4.05.2
4.11.3
1.40.1
410
00
C92-94
Leukae
miau
nspe
cified
(C95
)3
0.
..
.0.1
0.1.
..
..
0.2.
..
.0.0
0.00.0
010
00
C95
Leukae
mia(
C91-95
)60
912
6.93.8
3.52.2
2.81.6
2.42.0
2.22.2
2.94.8
5.05.8
7.812
.23.6
3.80.2
810
00
8C9
1-95
Othe
rand
unspecifie
d(O&
U)54
646
0.1.
.0.1
0.60.6
1.01.4
3.03.5
5.88.3
15.5
24.1
27.1
25.2
3.24.0
0.50
100
07
O&U
Allsitesb
utC4
4(AL
LbC4
4)13
401
1276
14.8
10.2
9.412
.019
.423
.828
.335
.643
.571
.110
9.219
3.031
6.447
6.365
1.970
3.378
.295
.211.13
100
0AL
LbC4
4Allsites(
ALL)
1720
516
6114
.810
.29.5
12.1
19.8
25.2
31.3
41.5
52.9
89.6
143.4
241.4
410.0
607.1
868.2
1036
.110
0.412
2.614
.2610
00
ALL
UNK,
Unknow
n;AS
R(W
),Ag
eStan
dardize
dRate
(WorldPo
pulation
);CU
M.,C
umula
tive;
MV,M
icroscopic
Verification;
DCO,
Death
Certif
icate
Only
†Percent
‡Ran
kbased
onhig
hestAS
Rexclu
ding:
Allsitesb
utC4
4and
Allsites
1
CSA - 5
MEXICO
,JAL
ISCO
(2006-2010)
Incid
ence
per1
00,00
0byA
geGr
oup(years)
Female
s
SITE
ALL
CASE
SUN
KAG
E0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
CRUD
ERA
TEAS
R(W
)CU
M.RA
TE(0-74)†
MV (%)
DCO
(%)
Rank‡
ICD1
0
Lip,o
ralcavity,a
ndph
arynx(
C00-14
)21
312
.0.1
.0.1
0.40.3
0.41.1
1.11.0
2.53.2
5.54.0
7.29.4
1.21.3
0.14
100
017
C00-14
Oesoph
agus
(C15
)43
3.
.0.1
..
0.10.1
.0.3
0.20.6
0.61.6
0.82.5
1.10.2
0.30.0
410
00
23C1
5Stom
ach(
C16)
482
43.
..
..
0.50.9
1.02.6
3.54.4
6.810
.913
.622
.421
.22.7
3.00.3
710
00
11C1
6Co
lon(C18
)67
152
.0.1
.0.1
0.10.5
1.72.8
4.16.1
7.99.7
15.4
17.8
25.3
22.7
3.84.2
0.50
100
0C1
8Re
ctum(C19
-20)
311
28.
..
..
0.50.9
0.91.3
2.33.4
5.58.1
8.89.0
11.8
1.81.9
0.22
100
0C1
9-20
Color
ectal
(C18
-20)
982
80.
0.1.
0.10.1
1.12.6
3.75.4
8.311.3
15.2
23.5
26.6
34.4
34.6
5.66.1
0.72
100
03
C18-20
Anus
(C21
)18
1.
..
..
..
0.1.
0.20.1
0.30.4
0.80.7
0.90.1
0.10.0
110
00
26C2
1Co
lon,rectum
anda
nus(
C18-21
)10
0081
.0.1
.0.1
0.11.1
2.63.7
5.48.5
11.4
15.5
23.9
27.4
35.1
35.4
5.76.2
0.73
100
0C1
8-21
Liver
(C22
)47
3.
..
..
0.10.2
.0.1
0.20.8
0.61.2
1.91.4
2.20.3
0.30.0
310
00
21C2
2Ga
llblad
der(C2
3-24
)31
627
..
..
0.20.1
0.30.6
0.71.0
2.86.2
7.112
.815
.914
.41.8
2.00.2
610
00
13C2
3-24
Pancreas
(C25
)19
26
..
0.1.
0.10.1
0.20.3
0.71.5
2.92.7
6.96.4
5.48.3
1.11.2
0.14
100
018
C25
Nose,sinu
ses(
C30-31
)24
1.
..
.0.1
0.10.1
..
0.30.4
0.6.
1.1.
1.10.1
0.10.0
110
00
25C3
0-31
Laryn
x(C3
2)45
1.
..
.0.2
0.1.
.0.1
0.10.3
0.62.4
0.82.5
2.20.3
0.30.0
410
00
22C3
2Lu
ng,tr
ache
aand
bron
chus
(C33
-34)
507
48.
..
0.1.
0.70.3
0.81.3
3.15.1
8.412
.319
.427
.518
.42.9
3.30.4
410
00
9C3
3-34
Melan
omao
fskin
(C43
)34
530
.0.1
..
0.60.9
0.91.9
2.82.4
3.66.5
5.14.0
8.714
.02.0
2.00.2
110
00
14C4
3Me
sothe
lioma
(C45
)25
4.
..
.0.1
..
..
.0.3
0.60.8
0.31.4
1.10.1
0.20.0
210
00
24C4
5Ka
posisarco
ma(C46
)9
0.
..
..
..
0.20.2
.0.1
..
.0.4
0.70.1
0.00.0
010
00
27C4
6Brea
st(C50
)58
1963
5.
..
.1.4
4.515
.935
.761
.178
.489
.410
5.410
7.110
1.210
2.484
.232
.935
.63.9
410
00
1C5
0Ce
rvixu
teri (C
53)
1850
62.
..
.1.2
3.48.5
14.9
17.2
26.1
29.3
29.3
37.4
31.6
25.3
36.1
10.5
11.0
1.16
100
02
C53
Corpus
uteri (
C54)
657
52.
.0.1
0.10.1
0.31.2
1.73.7
4.710
.014
.122
.520
.518
.813
.33.7
4.30.5
310
00
8C5
4Ov
ary(C5
6)88
954
0.10.4
0.51.3
2.22.7
4.45.4
7.89.7
10.7
14.1
13.6
13.3
18.5
13.8
5.05.2
0.56
100
04
C56
Kidn
ey(C64
)28
017
0.80.2
0.20.1
.0.3
0.50.6
1.82.3
3.93.3
7.78.5
8.77.7
1.61.8
0.21
100
015
C64
Blad
der(C6
7)25
826
0.10.1
..
0.10.2
0.40.3
0.41.0
2.94.0
6.17.7
10.9
14.0
1.51.6
0.19
100
016
C67
Brain
,CNS
(C70
-72)
413
291.7
2.01.3
0.90.7
1.11.3
2.32.2
2.92.6
5.46.9
5.68.7
5.02.3
2.50.2
410
00
12C7
0-72
Thyro
id(C73
)83
681
..
0.20.9
2.74.3
5.45.6
5.69.5
8.410
.310
.913
.314
.810
.14.7
4.90.5
110
00
5C7
3Ho
dgkin
disea
se(C81
)19
217
.0.2
0.70.9
1.51.2
1.91.0
0.10.7
1.11.0
1.22.7
3.62.6
1.11.0
0.10
100
019
C81
Non-Ho
dgkin
lymph
oma(
C82-85
,C96
)70
469
1.20.4
0.70.8
1.51.4
1.71.4
3.05.0
7.88.6
15.0
16.7
21.7
21.6
4.04.4
0.48
100
07
C82-85
,C96
Multip
lemy
eloma
(C88
+C90
)96
7.
.0.1
.0.1
0.10.1
0.20.4
0.91.3
1.72.8
3.22.9
2.80.5
0.60.0
710
00
20C8
8+C9
0Lymp
hoidleu
kaem
ia(C91
)31
09
5.53.3
2.81.3
0.60.5
0.60.5
0.31.0
1.30.6
1.62.1
1.12.0
1.81.9
0.12
100
0C9
1My
eloidleu
kaem
ia(C92
-94)
188
20.9
0.60.8
0.70.8
0.70.9
0.81.2
1.31.8
1.62.2
1.32.9
3.11.1
1.10.0
910
00
C92-94
Leukae
miau
nspe
cified
(C95
)1
0.
..
..
..
..
.0.1
..
..
.0.0
0.00.0
010
00
C95
Leukae
mia(
C91-95
)49
911
6.44.0
3.62.0
1.41.2
1.51.3
1.52.4
3.12.2
3.83.5
4.05.0
2.83.0
0.21
100
010
C91-95
Othe
rand
unspecifie
d(O&
U)72
789
..
.0.2
0.60.6
1.42.3
3.86.1
7.811.4
17.6
19.7
20.6
24.5
4.14.5
0.52
100
06
O&U
Allsitesb
utC4
4(AL
LbC4
4)17
491
1501
12.6
8.59.7
10.6
17.1
27.4
53.3
86.2
129.8
179.4
221.8
277.2
348.5
357.4
412.3
395.6
99.0
106.9
11.77
100
0AL
LbC4
4Allsites(
ALL)
2183
819
2212
.68.5
9.810
.817
.629
.257
.792
.814
2.219
8.725
8.332
5.544
0.248
0.960
4.969
4.112
3.613
3.114
.7510
00
ALL
UNK,
Unknow
n;AS
R(W
),Ag
eStan
dardize
dRate
(WorldPo
pulation
);CU
M.,C
umula
tive;
MV,M
icroscopic
Verification;
DCO,
Death
Certif
icate
Only
†Percent
‡Ran
kbased
onhig
hestAS
Rexclu
ding:
Allsitesb
utC4
4and
Allsites
1
CSA - 6
.01
.11
10
5 15 25 35 45 55 65 75+
Oesophagus (C15)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Stomach (C16)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Colon, rectum & anus (C18−21)
.01
.11
10
5 15 25 35 45 55 65 75+
Liver (C22)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Gallbladder (C23−24)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Pancreas (C25)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Larynx (C32)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Lung (C33−34)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Melanoma of skin (C43)
.01
.11
1010
010
00
5 15 25 35 45 55 65 75+
Breast (C50)
110
100
5 15 25 35 45 55 65 75+
Cervix uteri (C53)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Corpus uteri (C54)
Inci
denc
e ra
te (
log
scal
e) p
er 1
00,0
00 p
erso
n−ye
ars
Age in Years
Age−specific incidence rates per 100,000 person−years
MEXICO, JALISCO (2006−2010)
Males Females CSA - 7
.11
1010
0
5 15 25 35 45 55 65 75+
Ovary (C56)
.01
.11
10
5 15 25 35 45 55 65 75+
Penis (C60)
.01
.11
1010
010
00
5 15 25 35 45 55 65 75+
Prostate (C61)
.01
.11
10
5 15 25 35 45 55 65 75+
Testis (C62)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Kidney (C64)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Bladder (C67)
.11
10
5 15 25 35 45 55 65 75+
Brain, CNS (C70-72)
.11
1010
0
5 15 25 35 45 55 65 75+
Thyroid (C73)
.01
.11
10
5 15 25 35 45 55 65 75+
Hodgkin disease (C81)
.11
1010
0
5 15 25 35 45 55 65 75+
Non-Hodgkin (C82-85,96)
110
100
5 15 25 35 45 55 65 75+
Leukaemia (C91-95)
110
100
1000
5 15 25 35 45 55 65 75+
All sites but C44
Inci
denc
e ra
te (
log
scal
e) p
er 1
00,0
00 p
erso
n-ye
ars
Age in Years
Age-specific incidence rates per 100,000 person-years
MEXICO, JALISCO (2006-2010)
Males Females
CSA - 8
Country's Summary Tables and Figures
MEXICO1,2,3
(2006-2011)
1 Country's incidence rates were estimated using data from the histopathology-based cancer registry of the State of
Jalisco
2 National mortality data obtained from the WHO mortality database:
http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html
3 Methodological details are included in "Cancer in Central and South America: Methodology"
http://dx.doi.org/10.1016/j.canep.2016.07.020
CSA - 9
MEXICO* (2006-2010)Number of Cases in Major Diagnosis Groups
per Calendar Year
YEAR
SITE 2006n (%)2007n (%)
2008n (%)
2009n (%)
2010n (%)
TOTALn (%)
MALESLip, oral cavity, and pharynx (C00-C14) 68 (2.0) 83 (2.3) 57 (1.7) 64 (1.8) 85 (2.5) 357 (2.1)Digestive organs (C15-C26) 410 (12.3) 475 (13.4) 459 (13.3) 436 (12.4) 516 (15.3) 2296 (13.3)Respiratory organs (C30-C39) 227 (6.8) 243 (6.9) 219 (6.4) 267 (7.6) 240 (7.1) 1196 (7.0)Bone, cartilage, and skin (C40-C44) 805 (24.2) 872 (24.6) 895 (26.0) 867 (24.7) 850 (25.1) 4289 (24.9)Breast (C50) 4 (0.1) 7 (0.2) 8 (0.2) 3 (0.1) 8 (0.2) 30 (0.2)Male genitalia (C60-C63) 908 (27.3) 927 (26.2) 920 (26.7) 919 (26.2) 802 (23.7) 4476 (26.0)Urinary organs (C64-C68) 225 (6.8) 222 (6.3) 225 (6.5) 211 (6.0) 232 (6.9) 1115 (6.5)Eye, brain, and thyroid (C69-C75) 141 (4.2) 124 (3.5) 138 (4.0) 134 (3.8) 168 (5.0) 705 (4.1)Hematopoietic (C81-C96) 367 (11.0) 366 (10.3) 317 (9.2) 382 (10.9) 302 (8.9) 1734 (10.1)Other and unspecified 176 (5.3) 220 (6.2) 210 (6.1) 222 (6.3) 179 (5.3) 1007 (5.9)All sites 3331 (100.0) 3539 (100.0) 3448 (100.0) 3505 (100.0) 3382 (100.0) 17205 (100.0)
FEMALESLip, oral cavity, and pharynx (C00-C14) 50 (1.2) 40 (0.9) 47 (1.1) 34 (0.8) 42 (1.0) 213 (1.0)Digestive organs (C15-C26) 427 (10.1) 464 (10.0) 370 (8.5) 441 (10.1) 461 (10.8) 2163 (9.9)Respiratory organs (C30-C39) 119 (2.8) 128 (2.8) 113 (2.6) 124 (2.9) 118 (2.8) 602 (2.8)Bone, cartilage, and skin (C40-C44) 951 (22.5) 949 (20.5) 969 (22.2) 1004 (23.1) 976 (22.8) 4849 (22.2)Breast (C50) 1022 (24.2) 1258 (27.2) 1238 (28.4) 1137 (26.2) 1164 (27.2) 5819 (26.6)Female genitalia (C51-C58) 760 (18.0) 858 (18.6) 748 (17.1) 629 (14.5) 702 (16.4) 3697 (16.9)Urinary organs (C64-C68) 110 (2.6) 125 (2.7) 107 (2.5) 108 (2.5) 95 (2.2) 545 (2.5)Eye, brain, and thyroid (C69-C75) 255 (6.0) 260 (5.6) 290 (6.6) 257 (5.9) 266 (6.2) 1328 (6.1)Hematopoietic (C81-C96) 303 (7.2) 303 (6.6) 277 (6.3) 346 (8.0) 262 (6.1) 1491 (6.8)Other and unspecified 225 (5.3) 236 (5.1) 207 (4.7) 267 (6.1) 196 (4.6) 1131 (5.2)All sites 4222 (100.0) 4621 (100.0) 4366 (100.0) 4347 (100.0) 4282 (100.0) 21838 (100.0)
BOTH SEXESLip, oral cavity, and pharynx (C00-C14) 118 (1.6) 123 (1.5) 104 (1.3) 98 (1.2) 127 (1.7) 570 (1.5)Digestive organs (C15-C26) 837 (11.1) 939 (11.5) 829 (10.6) 877 (11.2) 977 (12.7) 4459 (11.4)Respiratory organs (C30-C39) 346 (4.6) 371 (4.5) 332 (4.2) 391 (5.0) 358 (4.7) 1798 (4.6)Bone, cartilage, and skin (C40-C44) 1756 (23.2) 1821 (22.3) 1864 (23.9) 1871 (23.8) 1826 (23.8) 9138 (23.4)Urinary organs (C64-C68) 335 (4.4) 347 (4.3) 332 (4.2) 319 (4.1) 327 (4.3) 1660 (4.3)Eye, brain, and thyroid (C69-C75) 396 (5.2) 384 (4.7) 428 (5.5) 391 (5.0) 434 (5.7) 2033 (5.2)Hematopoietic (C81-C96) 670 (8.9) 669 (8.2) 594 (7.6) 728 (9.3) 564 (7.4) 3225 (8.3)Other and unspecified 401 (5.3) 456 (5.6) 417 (5.3) 489 (6.2) 375 (4.9) 2138 (5.5)All sites 7553 (100.0) 8160 (100.0) 7814 (100.0) 7852 (100.0) 7664 (100.0) 39043 (100.0)
*Aggregated data from the histopathology-based cancer registry of the State of Jalisco
1
CSA - 10
MEXICO* (2006-2010)Age Standardized Rate (World Population) per 100,000
in Major Diagnosis Groups per Calendar Year
YEAR
SITE 2006ASR (%)2007
ASR (%)2008
ASR (%)2009
ASR (%)2010
ASR (%)TOTAL
ASR (%)
MALESLip, oral cavity, and pharynx (C00-C14) 2.6 (2.1) 3.1 (2.4) 2.1 (1.7) 2.2 (1.8) 2.8 (2.5) 2.6 (2.1)Digestive organs (C15-C26) 15.7 (12.5) 17.9 (13.7) 16.8 (13.6) 15.3 (12.6) 17.4 (15.3) 16.6 (13.5)Respiratory organs (C30-C39) 8.9 (7.1) 9.3 (7.2) 8.2 (6.6) 9.6 (8.0) 8.3 (7.3) 8.9 (7.2)Bone, cartilage, and skin (C40-C44) 30.0 (23.9) 32.4 (24.9) 32.0 (25.9) 30.0 (24.8) 28.6 (25.1) 30.6 (24.9)Breast (C50) 0.2 (0.1) 0.3 (0.2) 0.3 (0.2) 0.1 (0.1) 0.3 (0.3) 0.2 (0.2)Male genitalia (C60-C63) 35.9 (28.6) 34.8 (26.7) 34.0 (27.5) 32.2 (26.6) 27.6 (24.2) 32.7 (26.7)Urinary organs (C64-C68) 8.9 (7.1) 8.3 (6.4) 8.3 (6.7) 7.4 (6.1) 8.2 (7.2) 8.2 (6.7)Eye, brain, and thyroid (C69-C75) 4.8 (3.8) 4.3 (3.3) 4.5 (3.7) 4.3 (3.5) 5.4 (4.7) 4.7 (3.8)Hematopoietic (C81-C96) 12.2 (9.7) 12.1 (9.3) 10.4 (8.4) 12.2 (10.1) 9.6 (8.4) 11.3 (9.2)Other and unspecified 6.5 (5.2) 8.0 (6.1) 7.2 (5.8) 7.7 (6.4) 5.8 (5.1) 7.0 (5.7)All sites 125.5 (100.0) 130.4 (100.0) 123.5 (100.0) 121.0 (100.0) 113.7 (100.0) 122.6 (100.0)
FEMALESLip, oral cavity, and pharynx (C00-C14) 1.6 (1.2) 1.2 (0.9) 1.4 (1.1) 1.0 (0.8) 1.2 (1.0) 1.3 (1.0)Digestive organs (C15-C26) 14.5 (10.6) 15.1 (10.5) 11.4 (8.6) 13.2 (10.2) 13.6 (11.1) 13.5 (10.2)Respiratory organs (C30-C39) 4.2 (3.1) 4.3 (3.0) 3.6 (2.7) 3.9 (3.0) 3.4 (2.8) 3.9 (2.9)Bone, cartilage, and skin (C40-C44) 30.4 (22.1) 29.4 (20.4) 29.4 (22.1) 29.3 (22.6) 27.6 (22.4) 29.2 (21.9)Breast (C50) 33.3 (24.2) 39.4 (27.3) 37.8 (28.5) 33.8 (26.1) 33.7 (27.3) 35.6 (26.7)Female genitalia (C51-C58) 24.8 (18.1) 27.0 (18.7) 22.5 (16.9) 18.5 (14.3) 19.9 (16.1) 22.4 (16.8)Urinary organs (C64-C68) 3.8 (2.7) 3.9 (2.7) 3.5 (2.6) 3.4 (2.6) 2.8 (2.3) 3.4 (2.6)Eye, brain, and thyroid (C69-C75) 7.9 (5.7) 7.7 (5.4) 8.6 (6.4) 7.6 (5.9) 7.5 (6.1) 7.9 (5.9)Hematopoietic (C81-C96) 9.7 (7.1) 9.1 (6.3) 8.3 (6.2) 10.4 (8.1) 7.8 (6.3) 9.0 (6.8)Other and unspecified 7.2 (5.3) 7.1 (4.9) 6.4 (4.8) 8.1 (6.3) 5.8 (4.7) 6.9 (5.2)All sites 137.4 (100.0) 144.3 (100.0) 132.8 (100.0) 129.3 (100.0) 123.3 (100.0) 133.1 (100.0)
BOTH SEXESLip, oral cavity, and pharynx (C00-C14) 2.1 (1.6) 2.1 (1.5) 1.7 (1.3) 1.5 (1.2) 2.0 (1.7) 1.9 (1.5)Digestive organs (C15-C26) 15.0 (11.4) 16.4 (12.0) 13.9 (10.9) 14.2 (11.4) 15.3 (13.0) 15.0 (11.7)Respiratory organs (C30-C39) 6.4 (4.9) 6.6 (4.8) 5.7 (4.5) 6.5 (5.2) 5.6 (4.8) 6.2 (4.8)Bone, cartilage, and skin (C40-C44) 30.2 (23.0) 30.7 (22.4) 30.6 (23.9) 29.5 (23.7) 28.0 (23.7) 29.8 (23.4)Urinary organs (C64-C68) 6.1 (4.7) 5.9 (4.3) 5.7 (4.5) 5.2 (4.2) 5.3 (4.5) 5.6 (4.4)Eye, brain, and thyroid (C69-C75) 6.4 (4.9) 6.1 (4.4) 6.6 (5.2) 6.1 (4.9) 6.5 (5.5) 6.3 (5.0)Hematopoietic (C81-C96) 10.9 (8.3) 10.6 (7.7) 9.3 (7.3) 11.3 (9.0) 8.6 (7.3) 10.1 (7.9)Other and unspecified 6.9 (5.2) 7.5 (5.5) 6.7 (5.3) 7.9 (6.4) 5.8 (4.9) 7.0 (5.5)All sites 131.1 (100.0) 137.0 (100.0) 127.8 (100.0) 124.8 (100.0) 118.3 (100.0) 127.5 (100.0)
*Aggregated data from the histopathology-based cancer registry of the State of Jalisco
1
CSA - 11
MEXICO
*(20
06-201
0)Incid
ence
per1
00,00
0byA
geGr
oup(yea
rs)
Males
SITE
ALL
CASE
SUN
KAG
E0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
CRUD
ERA
TEAS
R(W
)CU
M.RA
TE(0-74)†
MV (%)
DCO
(%)
Rank‡
ICD1
0
Lip,o
ralcavity,a
ndph
arynx(
C00-14
)35
724
..
.0.2
0.50.5
0.41.1
1.42.7
4.98.3
9.113
.112
.118
.52.1
2.60.2
910
00
12C0
0-14
Oesoph
agus
(C15
)14
610
..
..
.0.1
.0.2
0.81.5
1.72.8
4.37.0
5.68.4
0.91.1
0.13
100
018
C15
Stom
ach(
C16)
643
530.1
..
..
0.31.3
2.12.8
4.97.4
11.4
16.0
23.8
31.5
37.6
3.84.6
0.55
100
05
C16
Colon
(C18
)66
247
..
.0.2
0.41.0
1.32.2
2.76.4
8.514
.616
.719
.833
.229
.53.9
4.70.5
810
00
C18
Rectu
m(C19
-20)
365
35.
.0.1
.0.1
0.40.7
1.51.9
2.34.9
6.78.7
13.4
15.9
17.7
2.12.6
0.31
100
0C1
9-20
Color
ectal
(C18
-20)
1027
82.
.0.1
0.20.4
1.42.1
3.74.6
8.713
.321
.325
.433
.249
.147
.26.0
7.40.8
910
00
2C1
8-20
Anus
(C21
)13
1.
..
..
.0.1
.0.1
0.10.4
.0.5
0.30.4
0.30.1
0.10.0
110
00
27C2
1Co
lon,rectum
anda
nus(
C18-21
)10
4083
..
0.10.2
0.41.4
2.23.7
4.78.8
13.8
21.3
25.8
33.5
49.5
47.5
6.17.5
0.90
100
0C1
8-21
Liver
(C22
)34
1.
..
..
..
.0.1
0.40.4
0.70.7
2.11.7
2.00.2
0.30.0
310
00
23C2
2Ga
llblad
der(C2
3-24
)13
917
..
..
.0.1
0.30.2
0.70.9
1.42.0
4.84.6
7.86.9
0.81.0
0.13
100
019
C23-24
Pancreas
(C25
)18
26
..
..
..
0.10.2
0.82.2
2.85.0
5.96.7
10.3
6.71.1
1.40.1
810
00
16C2
5No
se,sinu
ses(
C30-31
)31
00.1
0.1.
0.10.1
.0.4
0.10.4
0.1.
0.70.5
0.9.
2.00.2
0.20.0
210
00
26C3
0-31
Laryn
x(C3
2)30
612
..
..
.0.2
0.10.5
0.61.8
3.54.8
10.3
17.1
15.9
20.8
1.82.3
0.28
100
013
C32
Lung
,trache
aand
bron
chus
(C33
-34)
814
58.
..
0.1.
0.50.4
1.02.3
3.57.8
16.7
21.2
35.7
53.9
55.0
4.86.1
0.77
100
03
C33-34
Melan
omao
fskin
(C43
)30
124
.0.2
0.10.1
0.10.3
1.01.2
2.42.8
3.34.4
7.18.5
8.216
.51.8
2.10.2
210
00
14C4
3Me
sothe
lioma
(C45
)31
4.
..
0.1.
0.1.
0.10.2
0.20.4
0.40.7
1.20.4
1.70.2
0.20.0
210
00
24C4
5Ka
posisarco
ma(C46
)72
13.
..
.0.1
0.50.7
0.51.1
0.30.4
0.70.7
0.90.9
1.20.4
0.40.0
410
00
22C4
6Brea
st(C50
)30
3.
..
..
..
0.10.4
0.20.1
0.20.7
1.21.7
2.00.2
0.20.0
310
00
25C5
0Pe
nis(C60
)14
26
..
..
0.10.1
0.11.0
0.81.5
1.32.0
4.34.3
4.79.8
0.81.0
0.11
100
020
C60
Prostat
e(C6
1)37
7959
5.
..
0.1.
0.30.7
1.92.0
5.615
.743
.810
2.618
8.728
1.328
8.022
.128
.93.8
110
00
1C6
1Testis(
C62)
543
290.6
0.10.6
3.27.7
8.06.6
3.51.7
1.51.0
1.40.9
1.82.2
2.33.2
2.90.2
110
00
10C6
2Kidn
ey(C64
)46
628
1.20.3
0.20.1
0.20.4
0.41.3
2.14.7
5.89.4
12.1
17.4
25.9
14.2
2.73.4
0.43
100
09
C64
Blad
der(C6
7)63
164
..
..
0.10.2
0.40.7
1.43.1
5.06.7
18.3
27.1
32.7
54.1
3.74.6
0.53
100
06
C67
Brain
,CNS
(C70
-72)
416
272.1
1.80.8
0.40.9
1.51.8
2.51.9
2.94.9
6.78.5
5.58.6
4.92.4
2.70.2
710
00
11C7
0-72
Thyro
id(C73
)18
49
..
.0.1
0.40.9
1.31.4
1.61.6
1.73.7
3.93.4
5.64.3
1.11.2
0.13
100
017
C73
Hodg
kindis
ease
(C81
)23
121
0.20.6
1.01.3
1.61.5
1.01.2
0.81.5
1.41.4
1.63.0
3.93.8
1.31.4
0.12
100
015
C81
Non-Ho
dgkin
lymph
oma(
C82-85
,C96
)77
565
1.41.6
1.11.1
1.62.8
2.13.1
4.05.7
7.89.8
12.6
19.8
26.7
29.2
4.55.2
0.55
100
04
C82-85
,C96
Multip
lemy
eloma
(C88
+C90
)119
2.
..
..
0.10.1
.0.6
1.10.8
4.36.9
4.94.7
3.50.7
0.90.1
210
00
21C8
8+C9
0Lymp
hoidleu
kaem
ia(C91
)38
510
5.83.2
3.01.6
1.70.8
1.00.7
0.40.7
1.41.8
2.11.8
2.68.1
2.22.4
0.15
100
0C9
1My
eloidleu
kaem
ia(C92
-94)
221
21.0
0.70.4
0.61.0
0.81.3
1.21.8
1.61.5
2.83.0
4.05.2
4.11.3
1.40.1
410
00
C92-94
Leukae
miau
nspe
cified
(C95
)3
0.
..
.0.1
0.1.
..
..
0.2.
..
.0.0
0.00.0
010
00
C95
Leukae
mia(
C91-95
)60
912
6.93.8
3.52.2
2.81.6
2.42.0
2.22.2
2.94.8
5.05.8
7.812
.23.6
3.80.2
810
00
8C9
1-95
Othe
rand
unspecifie
d(O&
U)54
646
0.1.
.0.1
0.60.6
1.01.4
3.03.5
5.88.3
15.5
24.1
27.1
25.2
3.24.0
0.50
100
07
O&U
Allsitesb
utC4
4(AL
LbC4
4)13
401
1276
14.8
10.2
9.412
.019
.423
.828
.335
.643
.571
.110
9.219
3.031
6.447
6.365
1.970
3.378
.295
.211.13
100
0AL
LbC4
4Allsites(
ALL)
1720
516
6114
.810
.29.5
12.1
19.8
25.2
31.3
41.5
52.9
89.6
143.4
241.4
410.0
607.1
868.2
1036
.110
0.412
2.614
.2610
00
ALL
*Agg
rega
tedda
tafro
mthe
histop
atholo
gy-based
cancer
regis
tryof
theState
ofJalisco
UNK,
Unknow
n;AS
R(W
),Ag
eStan
dardize
dRate
(WorldPo
pulation
);CU
M.,C
umula
tive;
MV,M
icroscopic
Verification;
DCO,
Death
Certif
icate
Only
†Percent
‡Ran
kbased
onhig
hestAS
Rexclu
ding:
Allsitesb
utC4
4and
Allsites
1
CSA - 12
MEXICO
*(20
06-201
0)Incid
ence
per1
00,00
0byA
geGr
oup(yea
rs)
Female
s
SITE
ALL
CASE
SUN
KAG
E0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
CRUD
ERA
TEAS
R(W
)CU
M.RA
TE(0-74)†
MV (%)
DCO
(%)
Rank‡
ICD1
0
Lip,o
ralcavity,a
ndph
arynx(
C00-14
)21
312
.0.1
.0.1
0.40.3
0.41.1
1.11.0
2.53.2
5.54.0
7.29.4
1.21.3
0.14
100
017
C00-14
Oesoph
agus
(C15
)43
3.
.0.1
..
0.10.1
.0.3
0.20.6
0.61.6
0.82.5
1.10.2
0.30.0
410
00
23C1
5Stom
ach(
C16)
482
43.
..
..
0.50.9
1.02.6
3.54.4
6.810
.913
.622
.421
.22.7
3.00.3
710
00
11C1
6Co
lon(C18
)67
152
.0.1
.0.1
0.10.5
1.72.8
4.16.1
7.99.7
15.4
17.8
25.3
22.7
3.84.2
0.50
100
0C1
8Re
ctum
(C19
-20)
311
28.
..
..
0.50.9
0.91.3
2.33.4
5.58.1
8.89.0
11.8
1.81.9
0.22
100
0C1
9-20
Color
ectal
(C18
-20)
982
80.
0.1.
0.10.1
1.12.6
3.75.4
8.311.3
15.2
23.5
26.6
34.4
34.6
5.66.1
0.72
100
03
C18-20
Anus
(C21
)18
1.
..
..
..
0.1.
0.20.1
0.30.4
0.80.7
0.90.1
0.10.0
110
00
26C2
1Co
lon,rectum
anda
nus(
C18-21
)10
0081
.0.1
.0.1
0.11.1
2.63.7
5.48.5
11.4
15.5
23.9
27.4
35.1
35.4
5.76.2
0.73
100
0C1
8-21
Liver
(C22
)47
3.
..
..
0.10.2
.0.1
0.20.8
0.61.2
1.91.4
2.20.3
0.30.0
310
00
21C2
2Ga
llblad
der(C2
3-24
)31
627
..
..
0.20.1
0.30.6
0.71.0
2.86.2
7.112
.815
.914
.41.8
2.00.2
610
00
13C2
3-24
Pancreas
(C25
)19
26
..
0.1.
0.10.1
0.20.3
0.71.5
2.92.7
6.96.4
5.48.3
1.11.2
0.14
100
018
C25
Nose,sinu
ses(
C30-31
)24
1.
..
.0.1
0.10.1
..
0.30.4
0.6.
1.1.
1.10.1
0.10.0
110
00
25C3
0-31
Laryn
x(C3
2)45
1.
..
.0.2
0.1.
.0.1
0.10.3
0.62.4
0.82.5
2.20.3
0.30.0
410
00
22C3
2Lu
ng,tr
ache
aand
bron
chus
(C33
-34)
507
48.
..
0.1.
0.70.3
0.81.3
3.15.1
8.412
.319
.427
.518
.42.9
3.30.4
410
00
9C3
3-34
Melan
omao
fskin
(C43
)34
530
.0.1
..
0.60.9
0.91.9
2.82.4
3.66.5
5.14.0
8.714
.02.0
2.00.2
110
00
14C4
3Me
sothe
lioma
(C45
)25
4.
..
.0.1
..
..
.0.3
0.60.8
0.31.4
1.10.1
0.20.0
210
00
24C4
5Ka
posisarco
ma(C46
)9
0.
..
..
..
0.20.2
.0.1
..
.0.4
0.70.1
0.00.0
010
00
27C4
6Brea
st(C50
)58
1963
5.
..
.1.4
4.515
.935
.761
.178
.489
.410
5.410
7.110
1.210
2.484
.232
.935
.63.9
410
00
1C5
0Ce
rvixu
teri(C
53)
1850
62.
..
.1.2
3.48.5
14.9
17.2
26.1
29.3
29.3
37.4
31.6
25.3
36.1
10.5
11.0
1.16
100
02
C53
Corpus
uteri(
C54)
657
52.
.0.1
0.10.1
0.31.2
1.73.7
4.710
.014
.122
.520
.518
.813
.33.7
4.30.5
310
00
8C5
4Ov
ary(
C56)
889
540.1
0.40.5
1.32.2
2.74.4
5.47.8
9.710
.714
.113
.613
.318
.513
.85.0
5.20.5
610
00
4C5
6Kidn
ey(C64
)28
017
0.80.2
0.20.1
.0.3
0.50.6
1.82.3
3.93.3
7.78.5
8.77.7
1.61.8
0.21
100
015
C64
Blad
der(C6
7)25
826
0.10.1
..
0.10.2
0.40.3
0.41.0
2.94.0
6.17.7
10.9
14.0
1.51.6
0.19
100
016
C67
Brain
,CNS
(C70
-72)
413
291.7
2.01.3
0.90.7
1.11.3
2.32.2
2.92.6
5.46.9
5.68.7
5.02.3
2.50.2
410
00
12C7
0-72
Thyro
id(C73
)83
681
..
0.20.9
2.74.3
5.45.6
5.69.5
8.410
.310
.913
.314
.810
.14.7
4.90.5
110
00
5C7
3Ho
dgkin
disea
se(C81
)19
217
.0.2
0.70.9
1.51.2
1.91.0
0.10.7
1.11.0
1.22.7
3.62.6
1.11.0
0.10
100
019
C81
Non-Ho
dgkin
lymph
oma(
C82-85
,C96
)70
469
1.20.4
0.70.8
1.51.4
1.71.4
3.05.0
7.88.6
15.0
16.7
21.7
21.6
4.04.4
0.48
100
07
C82-85
,C96
Multip
lemy
eloma
(C88
+C90
)96
7.
.0.1
.0.1
0.10.1
0.20.4
0.91.3
1.72.8
3.22.9
2.80.5
0.60.0
710
00
20C8
8+C9
0Lymp
hoidleu
kaem
ia(C91
)31
09
5.53.3
2.81.3
0.60.5
0.60.5
0.31.0
1.30.6
1.62.1
1.12.0
1.81.9
0.12
100
0C9
1My
eloidleu
kaem
ia(C92
-94)
188
20.9
0.60.8
0.70.8
0.70.9
0.81.2
1.31.8
1.62.2
1.32.9
3.11.1
1.10.0
910
00
C92-94
Leukae
miau
nspe
cified
(C95
)1
0.
..
..
..
..
.0.1
..
..
.0.0
0.00.0
010
00
C95
Leukae
mia(
C91-95
)49
911
6.44.0
3.62.0
1.41.2
1.51.3
1.52.4
3.12.2
3.83.5
4.05.0
2.83.0
0.21
100
010
C91-95
Othe
rand
unspecifie
d(O&
U)72
789
..
.0.2
0.60.6
1.42.3
3.86.1
7.811.4
17.6
19.7
20.6
24.5
4.14.5
0.52
100
06
O&U
Allsitesb
utC4
4(AL
LbC4
4)17
491
1501
12.6
8.59.7
10.6
17.1
27.4
53.3
86.2
129.8
179.4
221.8
277.2
348.5
357.4
412.3
395.6
99.0
106.9
11.77
100
0AL
LbC4
4Allsites(
ALL)
2183
819
2212
.68.5
9.810
.817
.629
.257
.792
.814
2.219
8.725
8.332
5.544
0.248
0.960
4.969
4.112
3.613
3.114
.7510
00
ALL
*Agg
rega
tedda
tafro
mthe
histop
atholo
gy-based
cancer
regis
tryof
theState
ofJalisco
UNK,
Unknow
n;AS
R(W
),Ag
eStan
dardize
dRate
(WorldPo
pulation
);CU
M.,C
umula
tive;
MV,M
icroscopic
Verification;
DCO,
Death
Certif
icate
Only
†Percent
‡Ran
kbased
onhig
hestAS
Rexclu
ding:
Allsitesb
utC4
4and
Allsites
1
CSA - 13
MEXICO (2006-2010)Number of Deaths in Major Diagnosis Groups
per Calendar Year
YEAR
SITE 2006n (%)2007n (%)
2008n (%)
2009n (%)
2010n (%)
TOTALn (%)
MALESLip, oral cavity, and pharynx (C00-C14) 627 (2.0) 585 (1.9) 651 (2.0) 645 (2.0) 654 (1.9) 3162 (2.0)Digestive organs (C15-C26) 9711 (31.2) 9531 (30.6) 10227 (31.1) 10164 (30.8) 10373 (30.6) 50006 (30.9)Respiratory organs (C30-C39) 5224 (16.8) 4991 (16.0) 5152 (15.7) 4991 (15.1) 4977 (14.7) 25335 (15.6)Bone, cartilage, and skin (C40-C44) 225 (0.7) 239 (0.8) 262 (0.8) 230 (0.7) 302 (0.9) 1258 (0.8)Male genitalia (C60-C63) 5061 (16.2) 5226 (16.8) 5486 (16.7) 5563 (16.9) 5818 (17.2) 27154 (16.8)Urinary organs (C64-C68) 1504 (4.8) 1566 (5.0) 1644 (5.0) 1550 (4.7) 1739 (5.1) 8003 (4.9)Eye, brain, and thyroid (C69-C75) 1198 (3.8) 1185 (3.8) 1121 (3.4) 1219 (3.7) 1304 (3.9) 6027 (3.7)Hematopoietic (C81-C96) 3695 (11.9) 3740 (12.0) 3945 (12.0) 3997 (12.1) 4018 (11.9) 19395 (12.0)Other and unspecified 3902 (12.5) 4135 (13.3) 4352 (13.3) 4613 (14.0) 4685 (13.8) 21687 (13.4)All sites 31147 (100.0) 31198 (100.0) 32840 (100.0) 32972 (100.0) 33870 (100.0) 162027 (100.0)
FEMALESLip, oral cavity, and pharynx (C00-C14) 316 (1.0) 281 (0.9) 272 (0.8) 309 (0.9) 363 (1.0) 1541 (0.9)Digestive organs (C15-C26) 10143 (30.9) 9973 (30.4) 10426 (30.6) 10204 (29.7) 10531 (29.9) 51277 (30.3)Respiratory organs (C30-C39) 2406 (7.3) 2292 (7.0) 2364 (6.9) 2342 (6.8) 2430 (6.9) 11834 (7.0)Bone, cartilage, and skin (C40-C44) 199 (0.6) 208 (0.6) 225 (0.7) 223 (0.6) 229 (0.7) 1084 (0.6)Breast (C50) 4451 (13.5) 4518 (13.8) 4840 (14.2) 4805 (14.0) 4969 (14.1) 23583 (13.9)Female genitalia (C51-C58) 6388 (19.4) 6156 (18.8) 6288 (18.5) 6473 (18.9) 6425 (18.3) 31730 (18.8)Urinary organs (C64-C68) 924 (2.8) 1080 (3.3) 1069 (3.1) 969 (2.8) 1002 (2.8) 5044 (3.0)Eye, brain, and thyroid (C69-C75) 1175 (3.6) 1158 (3.5) 1232 (3.6) 1225 (3.6) 1303 (3.7) 6093 (3.6)Hematopoietic (C81-C96) 3128 (9.5) 3199 (9.8) 3272 (9.6) 3361 (9.8) 3408 (9.7) 16368 (9.7)Other and unspecified 4050 (12.3) 4242 (12.9) 4340 (12.8) 4762 (13.9) 4857 (13.8) 22251 (13.1)All sites 32855 (100.0) 32804 (100.0) 34034 (100.0) 34338 (100.0) 35192 (100.0) 169223 (100.0)
BOTH SEXESLip, oral cavity, and pharynx (C00-C14) 943 (1.5) 866 (1.4) 923 (1.4) 954 (1.4) 1017 (1.5) 4703 (1.4)Digestive organs (C15-C26) 19854 (31.0) 19504 (30.5) 20653 (30.9) 20368 (30.3) 20904 (30.3) 101283 (30.6)Respiratory organs (C30-C39) 7630 (11.9) 7283 (11.4) 7516 (11.2) 7333 (10.9) 7407 (10.7) 37169 (11.2)Bone, cartilage, and skin (C40-C44) 424 (0.7) 447 (0.7) 487 (0.7) 453 (0.7) 531 (0.8) 2342 (0.7)Urinary organs (C64-C68) 2428 (3.8) 2646 (4.1) 2713 (4.1) 2519 (3.7) 2741 (4.0) 13047 (3.9)Eye, brain, and thyroid (C69-C75) 2373 (3.7) 2343 (3.7) 2353 (3.5) 2444 (3.6) 2607 (3.8) 12120 (3.7)Hematopoietic (C81-C96) 6823 (10.7) 6939 (10.8) 7217 (10.8) 7358 (10.9) 7426 (10.8) 35763 (10.8)Other and unspecified 7952 (12.4) 8377 (13.1) 8692 (13.0) 9375 (13.9) 9542 (13.8) 43938 (13.3)All sites 64002 (100.0) 64002 (100.0) 66874 (100.0) 67310 (100.0) 69062 (100.0) 331250 (100.0)
1
CSA - 14
MEXICO (2006-2010)Age Standardized Mortality Rate (World Population) per 100,000
in Major Diagnosis Groups per Calendar Year
YEAR
SITE 2006ASMR (%)2007
ASMR (%)2008
ASMR (%)2009
ASMR (%)2010
ASMR (%)TOTAL
ASMR (%)
MALESLip, oral cavity, and pharynx (C00-C14) 1.9 (2.0) 1.7 (1.9) 1.9 (2.0) 1.8 (2.0) 1.8 (1.9) 1.8 (1.9)Digestive organs (C15-C26) 30.1 (31.6) 28.6 (30.9) 29.9 (31.4) 28.8 (31.1) 28.4 (30.7) 29.1 (31.1)Respiratory organs (C30-C39) 16.7 (17.6) 15.5 (16.8) 15.6 (16.4) 14.7 (15.8) 14.2 (15.3) 15.3 (16.4)Bone, cartilage, and skin (C40-C44) 0.7 (0.7) 0.7 (0.7) 0.7 (0.8) 0.6 (0.7) 0.8 (0.9) 0.7 (0.8)Male genitalia (C60-C63) 17.6 (18.5) 17.6 (19.0) 18.0 (18.9) 17.7 (19.1) 18.0 (19.5) 17.8 (19.0)Urinary organs (C64-C68) 4.7 (4.9) 4.7 (5.1) 4.8 (5.1) 4.4 (4.8) 4.8 (5.2) 4.7 (5.0)Eye, brain, and thyroid (C69-C75) 3.1 (3.2) 3.0 (3.2) 2.7 (2.9) 2.9 (3.2) 3.0 (3.3) 3.0 (3.2)Hematopoietic (C81-C96) 9.2 (9.7) 9.2 (10.0) 9.5 (10.0) 9.4 (10.1) 9.3 (10.0) 9.3 (10.0)Other and unspecified 11.2 (11.8) 11.5 (12.5) 12.0 (12.6) 12.3 (13.3) 12.2 (13.2) 11.8 (12.7)All sites 95.0 (100.0) 92.7 (100.0) 95.2 (100.0) 92.5 (100.0) 92.5 (100.0) 93.5 (100.0)
FEMALESLip, oral cavity, and pharynx (C00-C14) 0.8 (1.0) 0.7 (0.9) 0.6 (0.8) 0.7 (0.9) 0.8 (1.1) 0.7 (1.0)Digestive organs (C15-C26) 25.7 (32.7) 24.5 (32.1) 24.8 (32.3) 23.5 (31.3) 23.7 (31.6) 24.4 (32.0)Respiratory organs (C30-C39) 6.1 (7.8) 5.7 (7.5) 5.7 (7.4) 5.5 (7.3) 5.5 (7.4) 5.7 (7.5)Bone, cartilage, and skin (C40-C44) 0.5 (0.6) 0.5 (0.6) 0.5 (0.7) 0.5 (0.7) 0.5 (0.7) 0.5 (0.6)Breast (C50) 9.9 (12.6) 9.8 (12.9) 10.2 (13.3) 9.8 (13.1) 9.9 (13.2) 9.9 (13.0)Female genitalia (C51-C58) 14.6 (18.6) 13.8 (18.1) 13.6 (17.8) 13.5 (18.0) 13.0 (17.4) 13.7 (18.0)Urinary organs (C64-C68) 2.3 (2.9) 2.6 (3.5) 2.5 (3.3) 2.3 (3.0) 2.3 (3.0) 2.4 (3.1)Eye, brain, and thyroid (C69-C75) 2.7 (3.5) 2.6 (3.4) 2.7 (3.5) 2.6 (3.4) 2.7 (3.6) 2.7 (3.5)Hematopoietic (C81-C96) 6.9 (8.7) 6.8 (8.9) 6.8 (8.9) 6.8 (9.1) 6.8 (9.1) 6.8 (9.0)Other and unspecified 9.8 (12.4) 10.0 (13.1) 9.8 (12.8) 10.5 (14.0) 10.4 (13.9) 10.1 (13.3)All sites 78.6 (100.0) 76.3 (100.0) 76.7 (100.0) 75.1 (100.0) 74.9 (100.0) 76.2 (100.0)
BOTH SEXESLip, oral cavity, and pharynx (C00-C14) 1.3 (1.5) 1.2 (1.4) 1.2 (1.4) 1.2 (1.4) 1.2 (1.5) 1.2 (1.4)Digestive organs (C15-C26) 27.7 (32.3) 26.3 (31.6) 27.1 (31.9) 25.9 (31.3) 25.8 (31.2) 26.5 (31.6)Respiratory organs (C30-C39) 10.8 (12.6) 10.1 (12.1) 10.1 (11.9) 9.6 (11.6) 9.4 (11.3) 10.0 (11.9)Bone, cartilage, and skin (C40-C44) 0.6 (0.7) 0.6 (0.7) 0.6 (0.7) 0.6 (0.7) 0.6 (0.8) 0.6 (0.7)Urinary organs (C64-C68) 3.4 (3.9) 3.6 (4.3) 3.6 (4.2) 3.2 (3.9) 3.4 (4.1) 3.4 (4.1)Eye, brain, and thyroid (C69-C75) 2.9 (3.4) 2.8 (3.3) 2.7 (3.2) 2.7 (3.3) 2.9 (3.5) 2.8 (3.3)Hematopoietic (C81-C96) 7.9 (9.3) 7.9 (9.5) 8.1 (9.5) 8.0 (9.7) 7.9 (9.6) 8.0 (9.5)Other and unspecified 10.4 (12.1) 10.7 (12.8) 10.8 (12.7) 11.3 (13.7) 11.2 (13.6) 10.9 (13.0)All sites 85.7 (100.0) 83.4 (100.0) 84.7 (100.0) 82.7 (100.0) 82.6 (100.0) 83.7 (100.0)
1
CSA - 15
MEXICO
(200
6-20
10)
Morta
lityp
er10
0,000
byAg
eGroup
(yea
rs)
Males
SITE
ALL
DEAT
HSUN
KAG
E0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
CRUD
ERA
TEAS
MR (W)
CUM.
RATE
(0-74)†
Rank‡
ICD1
0
Lip,o
ralcavity,&
pharynx(
C00-14
)31
620
0.00.0
0.00.0
0.10.1
0.20.3
0.81.3
2.13.7
5.37.7
10.7
36.3
1.11.8
0.214
C00-14
Oesoph
agus
(C15
)33
282
0.00.0
0.00.0
0.00.1
0.10.3
0.51.2
2.03.3
5.89.9
12.8
40.6
1.22.0
0.212
C15
Stom
ach(
C16)
1447
48
0.00.0
0.00.1
0.20.6
1.12.2
3.95.7
9.013
.721
.934
.550
.018
0.45.2
8.40.7
4C1
6Co
lon(C18
)77
125
0.00.0
0.00.1
0.20.4
0.71.2
2.13.4
5.28.0
13.1
17.9
25.7
85.0
2.84.4
0.4C1
8Re
ctum
(C19
-C20
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
C19-C2
0Co
lorectal
(C18
-20)
00
..
..
..
..
..
..
..
..
0.00.0
0.024
C18-20
Anus
(C21
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
24C2
1Co
lon,rectum
anda
nus(
C18-21
)96
545
0.00.0
0.00.1
0.30.5
0.91.5
2.74.4
6.510
.216
.422
.233
.210
3.73.5
5.40.5
C18-21
Liver
(C22
)1186
618
0.30.1
0.10.1
0.20.2
0.30.7
1.53.1
5.510
.518
.233
.450
.216
1.44.3
7.10.6
5C2
2Ga
llblad
der(C2
3-24
)24
963
0.00.0
0.00.0
0.00.0
0.00.1
0.40.7
1.32.3
3.76.4
10.5
36.4
0.91.5
0.115
C23-24
Pancreas
(C25
)81
889
0.00.0
0.00.0
0.10.2
0.20.6
1.43.2
5.59.1
15.0
23.0
32.0
90.8
2.94.7
0.56
C25
Nose,sinu
ses(
C30-31
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
24C3
0-31
Laryn
x(C3
2)34
604
0.00.0
0.00.0
0.00.0
0.00.1
0.30.8
1.83.2
6.09.5
15.1
48.4
1.22.1
0.211
C32
Lung
(C33
-34)
2187
522
0.00.0
0.00.1
0.20.4
0.61.1
2.34.9
9.318
.535
.660
.210
5.030
2.37.9
13.2
1.22
C33-34
Melan
omao
fskin
(C43
)12
580
0.00.0
0.00.0
0.00.1
0.10.2
0.40.6
1.01.3
1.63.1
3.914
.20.5
0.70.1
18C4
3Me
sothe
lioma
(C45
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
24C4
5Ka
posisarco
ma(C46
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
24C4
6Brea
st(C50
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
24C5
0Pe
nis(C60
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
24C6
0Prostat
e(C6
1)25
186
200.0
0.00.0
0.00.0
0.00.0
0.10.3
0.92.9
8.121
.648
.410
2.360
5.79.1
17.0
0.91
C61
Testis(
C62)
1968
10.0
0.00.0
0.71.6
1.71.2
0.80.7
0.50.4
0.50.6
0.60.9
5.50.7
0.70.1
17C6
2Kidn
ey(C64
)50
812
0.20.1
0.00.1
0.10.1
0.20.4
1.12.3
4.16.9
10.2
12.7
17.3
46.9
1.82.8
0.39
C64
Blad
der(C6
7)29
222
0.00.0
0.00.0
0.00.0
0.10.1
0.30.6
1.12.1
3.76.8
10.8
53.1
1.11.8
0.113
C67
Brain
,CNS
(C70
-72)
5223
20.7
0.90.5
0.50.5
0.71.0
1.42.0
2.73.7
5.47.4
9.512
.124
.71.9
2.50.2
10C7
0-72
Thyro
id(C73
)80
41
0.00.0
0.00.0
0.00.0
0.00.1
0.20.2
0.60.8
1.42.4
3.48.3
0.30.5
0.020
C73
Hodg
kindis
ease
(C81
)13
380
0.00.1
0.10.2
0.30.4
0.30.3
0.40.6
0.91.0
1.52.3
2.610
.10.5
0.70.1
19C8
1No
n-Ho
dgkin
lymph
oma(
C82-85
,C96
)58
220
0.20.3
0.40.5
0.70.8
1.01.3
1.72.4
3.85.1
8.311.5
17.6
48.4
2.13.0
0.38
C82-85
,C96
Multip
lemy
eloma
(C88
+C90
)21
911
0.00.0
0.00.0
0.00.0
0.10.2
0.50.9
1.93.2
4.66.3
7.419
.10.8
1.20.1
16C8
8+C9
0Lymp
hoidleu
kaem
ia(C91
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
C91
Myelo
idleu
kaem
ia(C92
-94)
00
..
..
..
..
..
..
..
..
0.00.0
0.0C9
2-94
Leukae
miau
nspe
cified
(C95
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
C95
Leukae
mia(
C91-95
)10
044
62.2
2.52.7
3.72.7
2.22.2
2.33.0
3.24.1
4.76.5
9.914
.951
.33.6
4.40.3
7C9
1-95
Othe
rand
unspecifie
d(O&
U)21
687
140.9
0.70.9
1.72.0
2.33.0
3.75.6
8.312
.918
.629
.744
.565
.823
1.57.8
11.8
1.03
O&U
Allsites(
ALL)
1620
2712
04.6
4.74.8
8.09.2
10.3
12.8
17.8
29.6
48.5
80.5
132.1
224.9
364.8
578.5
2119
.058
.493
.57.7
ALL
UNK,
Unknow
n;AS
MR(W
),Ag
eStan
dardize
dMortality
Rate
(WorldPo
pulation
);CU
M.,C
umula
tive
†Percent
‡Ran
kbased
onhig
hestAS
MRexclu
ding:
Allsitesb
utC4
4
1
CSA - 16
MEXICO
(200
6-20
10)
Morta
lityp
er10
0,000
byAg
eGroup
(yea
rs)
Female
s
SITE
ALL
DEAT
HSUN
KAG
E0-4
5-9
10-14
15-19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75+
CRUD
ERA
TEAS
MR (W)
CUM.
RATE
(0-74)†
Rank‡
ICD1
0
Lip,o
ralcavity,&
pharynx(
C00-14
)15
410
0.00.0
0.00.0
0.10.1
0.10.2
0.30.5
0.81.2
1.92.4
3.816
.50.5
0.70.1
18C0
0-14
Oesoph
agus
(C15
)12
130
0.00.0
0.00.0
0.00.0
0.00.1
0.10.3
0.60.8
1.62.4
3.714
.20.4
0.60.0
19C1
5Stom
ach(
C16)
1250
99
0.00.0
0.00.1
0.20.5
1.01.8
3.05.2
7.110
.015
.120
.433
.612
2.64.2
5.80.5
5C1
6Co
lon(C18
)74
259
0.00.0
0.00.1
0.10.4
0.60.9
1.42.5
4.15.9
9.512
.620
.974
.72.5
3.50.3
C18
Rectu
m(C19
-C20
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
C19-C2
0Co
lorectal
(C18
-20)
00
..
..
..
..
..
..
..
..
0.00.0
0.025
C18-20
Anus
(C21
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
25C2
1Co
lon,rectum
anda
nus(
C18-21
)91
0711
0.00.0
0.00.1
0.20.4
0.71.1
1.93.2
5.17.2
11.5
15.4
25.6
89.7
3.14.3
0.4C1
8-21
Liver
(C22
)13
495
100.2
0.10.1
0.10.1
0.20.3
0.61.4
3.26.5
10.6
18.4
30.3
43.8
141.9
4.56.5
0.64
C22
Gallblad
der(C2
3-24
)57
544
0.00.0
0.00.0
0.00.0
0.10.2
0.71.7
3.34.9
8.912
.719
.156
.11.9
2.80.3
10C2
3-24
Pancreas
(C25
)91
9910
0.00.0
0.00.0
0.00.1
0.20.4
1.12.3
4.67.7
13.5
19.9
30.1
94.4
3.14.4
0.47
C25
Nose,sinu
ses(
C30-31
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
25C3
0-31
Laryn
x(C3
2)53
60
0.00.0
0.00.0
0.00.0
0.00.0
0.00.1
0.20.3
0.71.1
2.16.2
0.20.3
0.022
C32
Lung
(C33
-34)
1129
86
0.00.0
0.00.1
0.10.2
0.40.9
1.53.2
5.28.4
14.6
23.4
38.1
119.3
3.85.4
0.56
C33-34
Melan
omao
fskin
(C43
)10
841
0.00.0
0.00.0
0.00.1
0.10.2
0.40.5
0.50.8
1.41.5
2.610
.00.4
0.50.0
20C4
3Me
sothe
lioma
(C45
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
25C4
5Ka
posisarco
ma(C46
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
25C4
6Brea
st(C50
)23
583
140.0
0.00.0
0.00.1
0.82.8
5.811.0
17.9
23.7
29.3
30.9
32.4
38.0
113.8
7.99.9
1.02
C50
Cervixu
teri (C
53)
2142
819
0.00.0
0.00.0
0.21.0
2.75.0
9.514
.718
.521
.327
.332
.143
.212
4.87.2
9.20.9
3C5
3Co
rpus
uteri (
C54)
1818
10.0
0.00.0
0.00.0
0.00.1
0.10.4
0.71.2
2.03.7
4.35.2
11.7
0.60.8
0.117
C54
Ovary(
C56)
8484
30.0
0.00.1
0.20.3
0.50.8
1.53.0
5.27.4
9.912
.214
.218
.243
.72.9
3.70.4
8C5
6Kidn
ey(C64
)33
171
0.20.2
0.10.1
0.00.0
0.10.3
0.61.3
2.22.8
4.86.5
10.1
26.2
1.11.5
0.113
C64
Blad
der(C6
7)17
272
0.00.0
0.00.0
0.00.0
0.00.1
0.10.5
0.81.0
2.02.9
4.823
.80.6
0.90.1
15C6
7Brain
,CNS
(C70
-72)
4194
20.5
0.80.5
0.40.4
0.40.6
0.71.1
1.82.2
3.74.8
6.58.3
18.7
1.41.7
0.212
C70-72
Thyro
id(C73
)18
992
0.00.0
0.00.0
0.00.1
0.10.1
0.20.6
1.01.5
2.93.8
5.819
.60.6
0.90.1
14C7
3Ho
dgkin
disea
se(C81
)93
60
0.00.0
0.00.1
0.20.2
0.20.2
0.20.3
0.40.6
0.91.3
2.36.7
0.30.4
0.021
C81
Non-Ho
dgkin
lymph
oma(
C82-85
,C96
)47
520
0.20.1
0.20.3
0.50.5
0.60.7
1.01.6
2.53.7
6.08.2
11.9
36.2
1.62.1
0.211
C82-85
,C96
Multip
lemy
eloma
(C88
+C90
)18
460
0.00.0
0.00.0
0.00.0
0.00.1
0.30.6
1.32.3
3.44.5
5.513
.00.6
0.90.1
16C8
8+C9
0Lymp
hoidleu
kaem
ia(C91
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
C91
Myelo
idleu
kaem
ia(C92
-94)
00
..
..
..
..
..
..
..
..
0.00.0
0.0C9
2-94
Leukae
miau
nspe
cified
(C95
)0
0.
..
..
..
..
..
..
..
.0.0
0.00.0
C95
Leukae
mia(
C91-95
)88
342
2.02.2
2.12.3
1.91.7
1.82.0
2.32.9
3.44.8
6.38.1
11.2
34.0
3.03.4
0.39
C91-95
Othe
rand
unspecifie
d(O&
U)22
251
110.8
0.60.9
1.21.1
1.52.1
2.84.9
8.612
.717
.426
.435
.753
.319
5.87.5
10.1
0.91
O&U
Allsites(
ALL)
1692
2310
54.1
4.04.0
5.15.6
8.514
.624
.644
.375
.810
9.915
0.821
7.328
7.741
6.713
28.7
56.9
76.2
6.9AL
L
UNK,
Unknow
n;AS
MR(W
),Ag
eStan
dardize
dMortality
Rate
(WorldPo
pulation
);CU
M.,C
umula
tive
†Percent
‡Ran
kbased
onhig
hestAS
MRexclu
ding:
Allsitesb
utC4
4
1
CSA - 17
.01
.11
1010
0.0
01
5 15 25 35 45 55 65 75+
Oesophagus (C15)
.01
.11
1010
010
00.0
01
5 15 25 35 45 55 65 75+
Stomach (C16)
.01
.11
1010
010
00.0
01
5 15 25 35 45 55 65 75+
Colon, rectum & anus (C18-21)
.01
.11
1010
010
00
5 15 25 35 45 55 65 75+
Liver (C22)
.01
.11
1010
0.0
01
5 15 25 35 45 55 65 75+
Gallbladder (C23-24)
.01
.11
1010
0.0
01
5 15 25 35 45 55 65 75+
Pancreas (C25)
.01
.11
1010
0.0
01
5 15 25 35 45 55 65 75+
Larynx (C32)
.01
.11
1010
010
00
5 15 25 35 45 55 65 75+
Lung (C33-34)
.01
.11
1010
0.0
01
5 15 25 35 45 55 65 75+
Melanoma of skin (C43)
.01
.11
1010
010
00.0
01
5 15 25 35 45 55 65 75+
Breast (C50)
.01
.11
1010
010
00.0
01
5 15 25 35 45 55 65 75+
Cervix uteri (C53)
.01
.11
1010
0.0
01
5 15 25 35 45 55 65 75+
Corpus uteri (C54)
R
ates
(lo
g sc
ale)
per
100
,000
per
son-
year
s
Age in Years
*Data from the histopathology-based cancer registry of Jalisco
Age-specific incidence* and mortality rates per 100,000 person-years
MEXICO (2006-2010)
Incidence, Males Mortality, MalesIncidence, Females Mortality, Females
CSA - 18
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Ovary (C56)
.01
.11
10
5 15 25 35 45 55 65 75+
Penis (C60)
.01
.11
1010
010
00.0
01
5 15 25 35 45 55 65 75+
Prostate (C61)
.01
.11
10
5 15 25 35 45 55 65 75+
Testis (C62)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Kidney (C64)
.01
.11
1010
0.0
01
5 15 25 35 45 55 65 75+
Bladder (C67)
.11
1010
0
5 15 25 35 45 55 65 75+
Brain, CNS (C70-72)
.01
.11
1010
0.0
01
5 15 25 35 45 55 65 75+
Thyroid (C73)
.01
.11
1010
0
5 15 25 35 45 55 65 75+
Hodgkin disease (C81)
.11
1010
0
5 15 25 35 45 55 65 75+
Non-Hodgkin (C82-85,C96)
110
100
5 15 25 35 45 55 65 75+
Leukaemia (C91-95)
110
100
1000
1000
0
5 15 25 35 45 55 65 75+
All sites but C44
R
ates
(lo
g sc
ale)
per
100
,000
per
son-
year
s
Age in Years
*Data from the histopathology-based cancer registry of Jalisco
Age-specific incidence* and mortality rates per 100,000 person-years
MEXICO (2006-2010)
Incidence, Males Mortality, MalesIncidence, Females Mortality, Females
CSA - 19
0-40-4
5-95-9
10-1410-14
15-1915-19
20-2420-24
25-2925-29
30-3430-34
35-3935-39
40-4440-44
45-4945-49
50-5450-54
55-5955-59
60-6460-64
65-6965-69
70-7470-74
75+75+
0-40-4
5-95-9
10-1410-14
15-1915-19
20-2420-24
25-2925-29
30-3430-34
35-3935-39
40-4440-44
45-4945-49
50-5450-54
55-5955-59
60-6460-64
65-6965-69
70-7470-74
75+75+
319850
343554
359857
342801
321768
294091
269700
251754
223172
190103
155255
121256
93930
70629
50036
72762
305071
325192
344681
335560
325026
308289
286308
266400
237615
205851
171579
136370
106625
81218
59297
94955Males Females
0 50 100 150 200 250 300 350050100150200250300350400 400
Population in Thousands
2005 2010
*Aggregated population from Jalisco
Average annual person-yearsMEXICO* (2005-2010)
CSA - 20